BIO logo

Bio-Rad Laboratories, Inc. (BIO) Cash from operations

annual CFO:

$454.60M+$79.66M(+21.25%)
December 31, 2024

Summary

  • As of today (August 16, 2025), BIO annual cash flow from operations is $454.60 million, with the most recent change of +$79.66 million (+21.25%) on December 31, 2024.
  • During the last 3 years, BIO annual CFO has risen by +$870.04 million (+209.43%).
  • BIO annual CFO is now -68.34% below its all-time high of $1.44 billion, reached on December 31, 2022.

Performance

BIO Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

quarterly CFO:

$116.50M-$13.40M(-10.32%)
June 30, 2025

Summary

  • As of today (August 16, 2025), BIO quarterly cash flow from operations is $116.50 million, with the most recent change of -$13.40 million (-10.32%) on June 30, 2025.
  • Over the past year, BIO quarterly CFO has increased by +$18.90 million (+19.36%).
  • BIO quarterly CFO is now -60.43% below its all-time high of $294.38 million, reached on December 31, 2020.

Performance

BIO quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

TTM CFO:

$534.20M+$18.90M(+3.67%)
June 30, 2025

Summary

  • As of today (August 16, 2025), BIO TTM cash flow from operations is $534.20 million, with the most recent change of +$18.90 million (+3.67%) on June 30, 2025.
  • Over the past year, BIO TTM CFO has increased by +$188.09 million (+54.34%).
  • BIO TTM CFO is now -32.63% below its all-time high of $792.98 million, reached on September 30, 2021.

Performance

BIO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BIO Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.3%+19.4%+54.3%
3 y3 years+209.4%+118.7%+5.8%
5 y5 years-0.7%+26.5%+28.9%

BIO Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-68.3%+209.4%-28.8%+956.5%at high+174.8%
5 y5-year-68.3%+209.4%-60.4%+956.5%-32.6%+174.8%
alltimeall time-68.3%+209.4%-60.4%+307.3%-32.6%+6170.4%

BIO Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$116.50M(-10.3%)
$534.20M(+3.7%)
Mar 2025
-
$129.90M(+4.6%)
$515.30M(+13.2%)
Dec 2024
$454.60M(+21.2%)
$124.15M(-24.1%)
$455.20M(+10.5%)
Sep 2024
-
$163.65M(+67.7%)
$412.05M(+19.1%)
Jun 2024
-
$97.60M(+39.8%)
$346.12M(-0.1%)
Mar 2024
-
$69.80M(-13.8%)
$346.58M(-7.6%)
Dec 2023
$374.94M(-73.9%)
$81.00M(-17.1%)
$374.90M(+0.4%)
Sep 2023
-
$97.71M(-0.4%)
$373.51M(+30.2%)
Jun 2023
-
$98.07M(-0.1%)
$286.82M(+18.5%)
Mar 2023
-
$98.12M(+23.2%)
$242.03M(+24.5%)
Dec 2022
$1.44B(-445.7%)
$79.61M(+622.0%)
$194.40M(-31.9%)
Sep 2022
-
$11.03M(-79.3%)
$285.66M(-43.4%)
Jun 2022
-
$53.27M(+5.5%)
$504.99M(-16.7%)
Mar 2022
-
$50.49M(-70.4%)
$606.35M(-9.4%)
Dec 2021
-$415.44M(-172.2%)
$170.87M(-25.8%)
$669.46M(-15.6%)
Sep 2021
-
$230.36M(+49.0%)
$792.98M(+13.6%)
Jun 2021
-
$154.62M(+36.1%)
$698.28M(+9.8%)
Mar 2021
-
$113.61M(-61.4%)
$635.77M(+8.7%)
Dec 2020
$575.33M(+25.6%)
$294.38M(+117.0%)
$584.97M(+29.9%)
Sep 2020
-
$135.66M(+47.3%)
$450.40M(+8.7%)
Jun 2020
-
$92.12M(+46.7%)
$414.48M(-13.2%)
Mar 2020
-
$62.81M(-60.7%)
$477.76M(+4.3%)
Dec 2019
$457.90M(+60.4%)
$159.80M(+60.2%)
$457.90M(+13.6%)
Sep 2019
-
$99.75M(-35.8%)
$403.10M(+10.2%)
Jun 2019
-
$155.40M(+261.9%)
$365.63M(+26.9%)
Mar 2019
-
$42.94M(-59.1%)
$288.09M(+0.9%)
Dec 2018
$285.49M(+174.2%)
$105.01M(+68.6%)
$285.49M(+14.3%)
Sep 2018
-
$62.28M(-20.0%)
$249.85M(+15.6%)
Jun 2018
-
$77.86M(+93.0%)
$216.05M(+7.7%)
Mar 2018
-
$40.35M(-41.8%)
$200.69M(+92.7%)
Dec 2017
$104.14M(-51.9%)
$69.36M(+143.6%)
$104.14M(-19.6%)
Sep 2017
-
$28.48M(-54.4%)
$129.52M(-15.2%)
Jun 2017
-
$62.50M(-211.2%)
$152.66M(-8.8%)
Mar 2017
-
-$56.20M(-159.3%)
$167.31M(-22.6%)
Dec 2016
$216.43M(+16.2%)
$94.75M(+83.6%)
$216.07M(+37.4%)
Sep 2016
-
$51.61M(-33.1%)
$157.27M(-16.3%)
Jun 2016
-
$77.16M(-1135.9%)
$187.94M(+25.9%)
Mar 2016
-
-$7.45M(-120.7%)
$149.32M(-19.8%)
Dec 2015
$186.21M(-31.9%)
$35.95M(-56.3%)
$186.21M(-2.2%)
Sep 2015
-
$82.28M(+113.5%)
$190.47M(-4.2%)
Jun 2015
-
$38.53M(+30.9%)
$198.85M(-16.2%)
Mar 2015
-
$29.45M(-26.8%)
$237.19M(-13.2%)
Dec 2014
$273.31M(+55.8%)
$40.22M(-55.6%)
$273.31M(-10.0%)
Sep 2014
-
$90.65M(+17.9%)
$303.65M(+13.4%)
Jun 2014
-
$76.87M(+17.2%)
$267.82M(+27.1%)
Mar 2014
-
$65.57M(-7.1%)
$210.69M(+24.6%)
Dec 2013
$175.48M(-37.1%)
$70.55M(+28.7%)
$169.14M(-8.5%)
Sep 2013
-
$54.83M(+177.8%)
$184.82M(-8.2%)
Jun 2013
-
$19.74M(-17.8%)
$201.33M(-21.1%)
Mar 2013
-
$24.02M(-72.1%)
$255.24M(-4.2%)
Dec 2012
$278.90M(+7.3%)
$86.24M(+20.9%)
$266.48M(+1.8%)
Sep 2012
-
$71.34M(-3.1%)
$261.74M(+8.4%)
Jun 2012
-
$73.64M(+108.9%)
$241.56M(-13.2%)
Mar 2012
-
$35.26M(-56.7%)
$278.21M(+5.9%)
Dec 2011
$259.82M(+15.0%)
$81.50M(+59.3%)
$262.74M(-6.7%)
Sep 2011
-
$51.16M(-53.6%)
$281.63M(-5.3%)
Jun 2011
-
$110.30M(+457.6%)
$297.33M(+33.1%)
Mar 2011
-
$19.78M(-80.3%)
$223.42M(-1.1%)
Dec 2010
$225.91M(-30.5%)
$100.39M(+50.1%)
$225.91M(-6.4%)
Sep 2010
-
$66.87M(+83.8%)
$241.24M(-11.3%)
Jun 2010
-
$36.39M(+63.4%)
$271.87M(-20.3%)
Mar 2010
-
$22.27M(-80.8%)
$340.97M(+4.9%)
Dec 2009
$325.07M(+69.9%)
$115.72M(+18.7%)
$325.07M(+13.0%)
Sep 2009
-
$97.49M(-7.6%)
$287.69M(+21.7%)
Jun 2009
-
$105.49M(+1555.8%)
$236.32M(+18.2%)
Mar 2009
-
$6.37M(-91.9%)
$199.92M(+4.5%)
Dec 2008
$191.37M(-0.1%)
$78.34M(+69.9%)
$191.37M(-11.5%)
Sep 2008
-
$46.12M(-33.2%)
$216.18M(-3.9%)
Jun 2008
-
$69.09M(-3273.5%)
$225.06M(+11.4%)
Mar 2008
-
-$2.18M(-102.1%)
$202.04M(+5.5%)
Dec 2007
$191.58M
$103.15M(+87.6%)
$191.58M(+33.7%)
Sep 2007
-
$55.00M(+19.4%)
$143.29M(+2.2%)
Jun 2007
-
$46.07M(-464.5%)
$140.17M(-5.1%)
DateAnnualQuarterlyTTM
Mar 2007
-
-$12.64M(-123.0%)
$147.66M(+24.9%)
Dec 2006
$118.20M(+9.2%)
$54.86M(+5.8%)
$118.23M(+4.9%)
Sep 2006
-
$51.87M(-3.2%)
$112.76M(+22.6%)
Jun 2006
-
$53.56M(-227.3%)
$91.96M(+122.5%)
Mar 2006
-
-$42.07M(-185.2%)
$41.33M(-61.8%)
Dec 2005
$108.28M(-12.0%)
$49.39M(+59.0%)
$108.28M(-1.5%)
Sep 2005
-
$31.07M(+958.7%)
$109.92M(+6.3%)
Jun 2005
-
$2.94M(-88.2%)
$103.37M(-14.3%)
Mar 2005
-
$24.88M(-51.2%)
$120.67M(-2.0%)
Dec 2004
$123.09M(-3.6%)
$51.03M(+108.1%)
$123.09M(+11.8%)
Sep 2004
-
$24.52M(+21.2%)
$110.14M(-14.4%)
Jun 2004
-
$20.24M(-25.9%)
$128.59M(-3.5%)
Mar 2004
-
$27.31M(-28.3%)
$133.23M(+4.4%)
Dec 2003
$127.64M(+21.8%)
$38.08M(-11.4%)
$127.64M(+2.0%)
Sep 2003
-
$42.97M(+72.8%)
$125.17M(+9.4%)
Jun 2003
-
$24.87M(+14.5%)
$114.38M(+4.6%)
Mar 2003
-
$21.72M(-39.0%)
$109.34M(+3.4%)
Dec 2002
$104.80M(+5.3%)
$35.61M(+10.7%)
$105.76M(-4.3%)
Sep 2002
-
$32.18M(+62.2%)
$110.56M(+10.0%)
Jun 2002
-
$19.83M(+9.4%)
$100.47M(-13.0%)
Mar 2002
-
$18.14M(-55.1%)
$115.42M(+16.0%)
Dec 2001
$99.50M(+310.4%)
$40.41M(+83.0%)
$99.50M(+53.2%)
Sep 2001
-
$22.08M(-36.5%)
$64.97M(+31.8%)
Jun 2001
-
$34.78M(+1470.4%)
$49.28M(+52.6%)
Mar 2001
-
$2.21M(-62.3%)
$32.28M(+33.1%)
Dec 2000
$24.25M(-46.1%)
$5.88M(-8.1%)
$24.25M(-40.1%)
Sep 2000
-
$6.40M(-64.0%)
$40.47M(-7.8%)
Jun 2000
-
$17.79M(-405.5%)
$43.87M(+16.1%)
Mar 2000
-
-$5.82M(-126.3%)
$37.78M(-16.0%)
Dec 1999
$44.98M(+64.6%)
$22.10M(+125.5%)
$45.00M(+31.2%)
Sep 1999
-
$9.80M(-16.2%)
$34.30M(+3.9%)
Jun 1999
-
$11.70M(+735.7%)
$33.00M(+14.6%)
Mar 1999
-
$1.40M(-87.7%)
$28.80M(+5.5%)
Dec 1998
$27.34M(+29.5%)
$11.40M(+34.1%)
$27.30M(+33.2%)
Sep 1998
-
$8.50M(+13.3%)
$20.50M(-6.4%)
Jun 1998
-
$7.50M(-7600.0%)
$21.90M(+0.9%)
Mar 1998
-
-$100.00K(-102.2%)
$21.70M(+2.8%)
Dec 1997
$21.11M(-36.3%)
$4.60M(-53.5%)
$21.10M(-15.6%)
Sep 1997
-
$9.90M(+35.6%)
$25.00M(+51.5%)
Jun 1997
-
$7.30M(-1142.9%)
$16.50M(-31.5%)
Mar 1997
-
-$700.00K(-108.2%)
$24.10M(-27.4%)
Dec 1996
$33.15M(-13.3%)
$8.50M(+507.1%)
$33.20M(-16.2%)
Sep 1996
-
$1.40M(-90.6%)
$39.60M(-8.8%)
Jun 1996
-
$14.90M(+77.4%)
$43.40M(+13.9%)
Mar 1996
-
$8.40M(-43.6%)
$38.10M(-0.3%)
Dec 1995
$38.23M(-20.8%)
$14.90M(+186.5%)
$38.20M(+9.8%)
Sep 1995
-
$5.20M(-45.8%)
$34.80M(-6.2%)
Jun 1995
-
$9.60M(+12.9%)
$37.10M(-11.2%)
Mar 1995
-
$8.50M(-26.1%)
$41.80M(-13.5%)
Dec 1994
$48.27M(+114.3%)
$11.50M(+53.3%)
$48.30M(-15.9%)
Sep 1994
-
$7.50M(-47.6%)
$57.40M(+5.1%)
Jun 1994
-
$14.30M(-4.7%)
$54.60M(+37.9%)
Mar 1994
-
$15.00M(-27.2%)
$39.60M(+76.0%)
Dec 1993
$22.53M(+468.1%)
$20.60M(+338.3%)
$22.50M(-355.7%)
Sep 1993
-
$4.70M(-771.4%)
-$8.80M(-269.2%)
Jun 1993
-
-$700.00K(-66.7%)
$5.20M(+23.8%)
Mar 1993
-
-$2.10M(-80.4%)
$4.20M(+5.0%)
Dec 1992
$3.96M(-4.1%)
-$10.70M(-157.2%)
$4.00M(-81.6%)
Sep 1992
-
$18.70M(-1200.0%)
$21.70M(+933.3%)
Jun 1992
-
-$1.70M(-26.1%)
$2.10M(-63.2%)
Mar 1992
-
-$2.30M(-132.9%)
$5.70M(+39.0%)
Dec 1991
$4.14M(-65.8%)
$7.00M(-877.8%)
$4.10M(-1466.7%)
Sep 1991
-
-$900.00K(-147.4%)
-$300.00K(-105.9%)
Jun 1991
-
$1.90M(-148.7%)
$5.10M(+34.2%)
Mar 1991
-
-$3.90M(-250.0%)
$3.80M(-68.6%)
Dec 1990
$12.09M(+39.8%)
$2.60M(-42.2%)
$12.10M(+27.4%)
Sep 1990
-
$4.50M(+650.0%)
$9.50M(+90.0%)
Jun 1990
-
$600.00K(-86.4%)
$5.00M(+13.6%)
Mar 1990
-
$4.40M
$4.40M
Dec 1988
$8.64M(-242.6%)
-
-
Dec 1987
-$6.06M(-200.0%)
-
-
Dec 1986
$6.07M(+96.2%)
-
-
Dec 1985
$3.09M(-222.6%)
-
-
Dec 1984
-$2.52M
-
-

FAQ

  • What is Bio-Rad Laboratories, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. annual CFO year-on-year change?
  • What is Bio-Rad Laboratories, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. quarterly CFO year-on-year change?
  • What is Bio-Rad Laboratories, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. TTM CFO year-on-year change?

What is Bio-Rad Laboratories, Inc. annual cash flow from operations?

The current annual CFO of BIO is $454.60M

What is the all time high annual CFO for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high annual cash flow from operations is $1.44B

What is Bio-Rad Laboratories, Inc. annual CFO year-on-year change?

Over the past year, BIO annual cash flow from operations has changed by +$79.66M (+21.25%)

What is Bio-Rad Laboratories, Inc. quarterly cash flow from operations?

The current quarterly CFO of BIO is $116.50M

What is the all time high quarterly CFO for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high quarterly cash flow from operations is $294.38M

What is Bio-Rad Laboratories, Inc. quarterly CFO year-on-year change?

Over the past year, BIO quarterly cash flow from operations has changed by +$18.90M (+19.36%)

What is Bio-Rad Laboratories, Inc. TTM cash flow from operations?

The current TTM CFO of BIO is $534.20M

What is the all time high TTM CFO for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high TTM cash flow from operations is $792.98M

What is Bio-Rad Laboratories, Inc. TTM CFO year-on-year change?

Over the past year, BIO TTM cash flow from operations has changed by +$188.09M (+54.34%)
On this page